Aeon Biopharma Inc (AEON)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Operating Expenses | 5,933 | 5,510 | 2,493 | 4,338 | 462 |
| Operating Income | -5,933 | -5,510 | -2,493 | -4,338 | -462 |
| Other Income | -5,860 | -31,627 | -2,045 | -2,304 | 9,557 |
| Pre-tax Income | -11,793 | -37,137 | -4,538 | -6,642 | 9,095 |
| Net Income Continuous | -11,793 | -37,137 | -4,538 | -6,642 | 9,095 |
| Net Income | $-11,793 | $-37,137 | $-4,538 | $-6,642 | $9,095 |
| EPS Basic Total Ops | -0.29 | -5.24 | -0.39 | -0.60 | 2.28 |
| EPS Basic Continuous Ops | -0.29 | -5.25 | -0.39 | -0.60 | 2.28 |
| EPS Diluted Total Ops | -0.29 | -5.24 | -0.39 | -0.60 | 2.28 |
| EPS Diluted Continuous Ops | -0.29 | -5.25 | -0.39 | -0.60 | 2.28 |
| EPS Diluted Before Non-Recurring Items | N/A | -3.72 | -0.39 | -0.60 | -0.09 |
| EBITDA(a) | $-5,914 | $-5,490 | $-2,474 | $-4,318 | $-443 |